title: Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506.
authors.affiliation: Department of Surgery, University of Pittsburgh, Pennsylvania.
authors.forename: R J
authors.initials: RJ
authors.lastname: Keenan
authors.forename: G
authors.initials: G
authors.lastname: Eiras
authors.forename: G J
authors.initials: GJ
authors.lastname: Burckart
authors.forename: R S
authors.initials: RS
authors.lastname: Stuart
authors.forename: R L
authors.initials: RL
authors.lastname: Hardesty
authors.forename: G
authors.initials: G
authors.lastname: Vogelsang
authors.forename: B P
authors.initials: BP
authors.lastname: Griffith
authors.forename: A
authors.initials: A
authors.lastname: Zeevi
mesh_terms: D000001:Calcimycin; D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects*; D066298:In Vitro Techniques; D008213:Lymphocyte Activation / Q000187:drug effects; D007959:Lymphocyte Culture Test, Mixed; D010835:Phytohemagglutinins; D016559:Tacrolimus / Q000494:pharmacology; D013792:Thalidomide / Q000494:pharmacology*
chemical_list: D010835:Phytohemagglutinins; D000001:Calcimycin; D013792:Thalidomide; D016572:Cyclosporine; D016559:Tacrolimus